User profiles for R. Postuma
Ronald PostumaMcGill University, University of Montreal Verified email at mcgill.ca Cited by 39764 |
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
…, S Fahn, RB Postuma… - Movement …, 2017 - Wiley Online Library
This article reviews and summarizes 200 years of Parkinson's disease. It comprises a relevant
history of Dr. James Parkinson's himself and what he described accurately and what he …
history of Dr. James Parkinson's himself and what he described accurately and what he …
MDS research criteria for prodromal Parkinson's disease
This article describes research criteria and probability methodology for the diagnosis of
prodromal PD. Prodromal disease refers to the stage wherein early symptoms or signs of PD …
prodromal PD. Prodromal disease refers to the stage wherein early symptoms or signs of PD …
MDS clinical diagnostic criteria for Parkinson's disease
RB Postuma, D Berg, M Stern, W Poewe… - Movement …, 2015 - Wiley Online Library
This document presents the Movement Disorder Society Clinical Diagnostic Criteria for
Parkinson's disease (PD). The Movement Disorder Society PD Criteria are intended for use in …
Parkinson's disease (PD). The Movement Disorder Society PD Criteria are intended for use in …
[HTML][HTML] Trial of prasinezumab in early-stage Parkinson's disease
…, T Simuni, K Marek, RB Postuma… - … England Journal of …, 2022 - Mass Medical Soc
Background Aggregated α-synuclein plays an important role in the pathogenesis of Parkinson’s
disease. The monoclonal antibody prasinezumab, directed at aggregated α-synuclein, is …
disease. The monoclonal antibody prasinezumab, directed at aggregated α-synuclein, is …
Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder
Objective: Idiopathic REM sleep behavior disorder (RBD) is a potential preclinical marker for
the development of neurodegenerative diseases, particularly Parkinson disease (PD) and …
the development of neurodegenerative diseases, particularly Parkinson disease (PD) and …
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
Idiopathic REM sleep behaviour disorder (iRBD) is a powerful early sign of Parkinson’s
disease, dementia with Lewy bodies, and multiple system atrophy. This provides an …
disease, dementia with Lewy bodies, and multiple system atrophy. This provides an …
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about
the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in …
the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in …
[HTML][HTML] Trial of cinpanemab in early Parkinson's disease
…, F Stocchi, CM Tanner, RB Postuma… - … England Journal of …, 2022 - Mass Medical Soc
Background Aggregated α-synuclein plays an important role in Parkinson’s disease
pathogenesis. Cinpanemab, a human-derived monoclonal antibody that binds to α-synuclein, is …
pathogenesis. Cinpanemab, a human-derived monoclonal antibody that binds to α-synuclein, is …
New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes
… Conflict of Interest Disclosures: Dr Postuma received personal compensation for travel and
speaker fees from Novartis Canada, Biotie, and Teva Neurosciences and is funded by grants …
speaker fees from Novartis Canada, Biotie, and Teva Neurosciences and is funded by grants …
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease
With advances in knowledge disease, boundaries may change. Occasionally, these changes
are of such a magnitude that they require redefinition of the disease. In recognition of the …
are of such a magnitude that they require redefinition of the disease. In recognition of the …